Zylo Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zylo Therapeutics

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: donpat	2/1/2018 3:09:29 PM
	Read Replies (1) of 19

I'm enthralled with the possibilities: 1. A composition for releasing nitric oxide (NO) comprising nitric oxide encapsulated in a matrix of chitosan, polyethylene glycol (PEG), and tetra-methoxy-ortho-silicate (TMOS). 30. A method of treating an infection in a subject comprising administering to the subject an amount of the composition of claim 1 effective to treat the infection, wherein the infection is a bacterial, viral, fungal or parasitic. patft.uspto.gov

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next